Organic compounds -- part of the class 532-570 series – Organic compounds – Oxygen containing
Patent
1997-11-19
2000-01-25
Dees, Jose' G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Oxygen containing
C07C 4500
Patent
active
060180803
ABSTRACT:
The invention relates to a process for the production of microfluidized particles of atovaquone having improved bioavailability.
REFERENCES:
patent: 2533648 (1950-05-01), Fieser et al.
patent: 3347830 (1967-10-01), Rogers
patent: 3367742 (1968-02-01), Sarett
patent: 4783389 (1988-11-01), Trout et al.
patent: 4963367 (1990-10-01), Ecanow
patent: 4981874 (1991-01-01), Latter et al.
patent: 4990640 (1991-02-01), Tsutsui et al.
patent: 5053418 (1991-10-01), Latter et al.
patent: 5053432 (1991-10-01), Hudson et al.
patent: 5155080 (1992-10-01), Elder et al.
patent: 5206268 (1993-04-01), Latter et al.
patent: 5225184 (1993-07-01), Latter et al.
patent: 5225500 (1993-07-01), Elder et al.
patent: 5310762 (1994-05-01), Latter et al.
patent: 5321106 (1994-06-01), LaPointe
patent: 5322902 (1994-06-01), Schreck et al.
patent: 5387568 (1995-02-01), Ewen et al.
patent: 5766522 (1998-06-01), Daly et al.
VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands, Jul. 19-24, 1991, "Final Program & Oral Abstracts".
Wofsy, pp. 377-401, Chapter 36, 1986.
Fieser, et al., vol. 70, pp. 3156-3165, 1948.
Hughs, Parasitology Today, vol. 3,, No. 11, pp. 332-335, 1887.
Parsons, 10 pages, issued Aug. 7, 1989.
Discriminant Analysis and Structure-Activity Relationships 1. Naphthoquinone; J. Med. Chem; vol. 21; No. 4; 1978; pp. 369-374.
Role of The Naphthoquinone Moiety In The Biological Activities of Sakyomicin A: J. Antibiot. vol. 39; No. 4; 1986; pp. 557-563.
Inhibition of Thioredoxin Reductase (E.C. 1.6.4.5) by Antitumor Quinones; Free Rad. Res. Commun. vol. 8; No. 4-6; 1990; pp. 365-372.
English Language Abstract of Japanese Laid-Open Patent Publication No. 4-337308, 1991.
Young Taek Son et al. of The Korean Pharmacological Society, Pharmacology, Korean Pharmacological Society, .sctn.1. "Introduction--5.1 Efficacy, .sctn.5, Bioavailability--1.2 Physico-chemical Property of a Medicament Affecting Absorption," Published in Korea by by Moon Sung Sa, 98-31, Sinsul-dong, Dongdaemun-ku, Seoul, Korea (Mar. 20, 1991).
Badio Barbara
Dees Jos,e G.
Glaxo Wellcome Inc.
LandOfFree
Atovaquone pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Atovaquone pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atovaquone pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316973